Navigation Links
NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
Date:12/2/2009

ROCKVILLE, Md., Dec. 2 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.

In Stage A of this study, 1,000 healthy volunteers aged 18 to 64 years old were enrolled to receive two doses of 5 mcg, 15 mcg or 45 mcg of Novavax's 2009 H1N1 pandemic influenza VLP or a placebo to determine the safety and immunogenicity of the vaccine. The DSMB reviewed preliminary safety and immunogenicity data 14 days post dose one from a subset of approximately 500 subjects enrolled in this stage of the trial. The vaccine was found to be well tolerated at all three dose levels and exhibited no systemic side effects in this review period. Local site reactions were mild. In this subset of 500 subjects from Stage A, the hemagglutinin inhibition (HAI) antibody titers 14 days post dose one in the 15 and 45 mcg arms met the seroconversion and seroprotection criteria recommended by the U.S. and European regulatory authorities. Based on these findings, the DSMB recommended that the study proceed to Stage B of testing in which vaccine safety will be evaluated in 3,000 subjects with a 15 mcg single dose regimen. The safety and immunogenicity data from all 1,000 subjects in Stage A will be available in January, 2010.

Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax, stated: "We believe this is the best possible outcome for our vaccine development program because it suggests that a single 15 mcg dose of our 2009 H1N1 VLP pandemic influenza vacci
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
2. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
4. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
5. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
6. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
7. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
8. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
9. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
10. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Sept. 16, 2014 Research and Markets ... Market 2014-2018" report to their offering. ... of animals. Animal vaccines are generally prepared from weakened or ... their healthy state. Some of the animal vaccines are also ... protein subunits or toxic components. These components ...
(Date:9/16/2014)... 2014  Advanced Medical Isotope Corporation ("AMIC") ... engaged primarily in the development of brachytherapy ... therapeutic applications, today announced that a patent ... brachytherapy products.  AMIC,s rights for the newly ... Battelle, under which AMIC exclusively licensed technologies ...
(Date:9/16/2014)... TUCSON, Ariz. , Sept. 16, 2014 ... describe in a case report the first ... (TAH-t) in a 13- year-old boy with failing Fontan ... When he was 3 years old, the patient ... condition known as functional single ventricle. "The Fontan operation ...
Breaking Medicine Technology:Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 2Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 2Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 413-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 213-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 3
... breakthrough in mental health has been developed, a cooperative ... Foundation; a preventative care program called "Safe ,til Stable." ... time of need through our live 24-hour emergency response ... the trauma experienced by individuals impacted with bipolar disorder. ...
... A Chicago woman will be among the first in the country to, ... get rid of Gastrointestinal Esophageal Reflux Disease (GERD), ... transorally, through the mouth. ... the body, the doctor uses a device to, ...
Cached Medicine Technology:Break-through Preventative Care Program for People Living With Bipolar Disorder 2New Incision-Less Procedure for REFLUX - Experts Consider it to Be Gold Standard for REFLUX 2
(Date:9/16/2014)... Sept. 16, 2014 (HealthDay News) -- Modern forensic techniques ... injuries might have killed King Richard III, the last ... analysis of the king,s skeletal remains, using whole-body CT ... detailed account of the 11 injuries he suffered at ... Aug. 22, 1485. The modern forensics revealed that ...
(Date:9/16/2014)... Not all recovery plans are alike, and ... sure all their patients are receiving the treatment that ... the newly-introduced online therapy. Millennium Treatment Group recently launched ... opportunity to seek treatment from home. , With online ... care at a distance. They provide patients with all ...
(Date:9/16/2014)... 16, 2014 Duke’s Chowder House Lake ... Rebls and Gratafy for a fun evening of ... is firmly cemented. With the growth of companies in these sectors, ... people who work in tech and at startups to connect with ... are happy to host events for their peers to meet and ...
(Date:9/16/2014)... 14, 2014 A new clinical trial ... and drug-eluting balloons (DEB) in treating in-stent ... EES provided superior late angiographic results and ... were reported today at the 26th annual ... by the Cardiovascular Research Foundation (CRF), TCT ...
(Date:9/16/2014)... Programs and policies that promote health and ... dollars in savings for the US health system, according ... help spur these types of improvements, the National Quality ... from across the country to field test the NQF ... handbook designed to assist groups working together to improve ...
Breaking Medicine News(10 mins):Health News:Modern Forensics Provides Clues to Death of Richard III 2Health News:Millennium Treatment Group Now Offers Online Therapy 2Health News:Seattle Seafood Restaurant Duke’s Chowder House Partners with Rebls & Gratafy for Tech Networking Happy Hour Event. 2Health News:Seattle Seafood Restaurant Duke’s Chowder House Partners with Rebls & Gratafy for Tech Networking Happy Hour Event. 3Health News:Results of RIBS IV trial reported at TCT 2014 2Health News:NQF Seeks Field Testing Groups for Population Health Guide 2Health News:NQF Seeks Field Testing Groups for Population Health Guide 3
... the past two decades, medication errors have dramatically increased. DecisionHealth, ... potentially harmful medication errors. , ... Gaithersburg, MD (PRWEB) ... Health Ledger,s recent drug overdose, increased dramatically over the past two ...
... Ind., Aug. 14 Jay C stores are asking,customers ... purchased with,"sell by" dates of July 2 through August ... by Nebraska Beef. Customers should return the ground beef,to ... The recall involves 29 stores Jay C operates in ...
... the Treeman, and the American Doctor Racing to Cure Him on Sunday, ... ... SPRING, Md., Aug. 14 The bizarre growths,covering his body have made Indonesia,s ... Discovery,Health will go beyond the headlines and the tabloids to present the,dramatic true ...
... & enforceable union,election ground rules, ORANGE, Calif., Aug. ... United Healthcare Workers - West:, Caregivers who work ... open letter to the Sisters of St. Joseph of ... the unlawful threats and,intimidation of workers who support forming ...
... Aug. 13 As reported in publications and news,outlets ... "buck" teeth was replaced at the summer games opening ... the decision spawned,disbelief around the globe, sadly, the phenomenon ... of their teeth is nothing new., In a ...
... Corporation, a leading,international manufacturer, marketer, and supplier of ... its financial,results for the second quarter of 2008., ... quarter were $275.2 million, an,increase of 13.9% over ... quarter of,2007. Excluding the impact of favorable foreign ...
Cached Medicine News:Health News:Fatalities From Medication Errors at Home Up Dramatically - DecisionHealth Offers Solutions 2Health News:Fatalities From Medication Errors at Home Up Dramatically - DecisionHealth Offers Solutions 3Health News:Discovery Health Offers the Definitive Look at Indonesia's 'Treeman' in TREEMAN: SEARCH FOR THE CURE 2Health News:Discovery Health Offers the Definitive Look at Indonesia's 'Treeman' in TREEMAN: SEARCH FOR THE CURE 3Health News:As Charges Mount, Caregivers and Supporters Call on Sisters of St. Joseph of Orange to Help Stop Unlawful Intimidation of Workers 2Health News:Summer Games 'Swap' Raises Questions About Image, Oral Health 2Health News:Pregis Announces Second Quarter 2008 Financial Results 2Health News:Pregis Announces Second Quarter 2008 Financial Results 3Health News:Pregis Announces Second Quarter 2008 Financial Results 4Health News:Pregis Announces Second Quarter 2008 Financial Results 5Health News:Pregis Announces Second Quarter 2008 Financial Results 6Health News:Pregis Announces Second Quarter 2008 Financial Results 7Health News:Pregis Announces Second Quarter 2008 Financial Results 8Health News:Pregis Announces Second Quarter 2008 Financial Results 9Health News:Pregis Announces Second Quarter 2008 Financial Results 10Health News:Pregis Announces Second Quarter 2008 Financial Results 11Health News:Pregis Announces Second Quarter 2008 Financial Results 12
... Ruschelit® PVC. 2 eyes, oral. ... patient age. X-ray opaque line. Graduated. ... Designed to reduce kinking of the ... Ruschelit® PVC adapts to the anatomical ...
... Set® Tube with stylet inside. Sterile, ... uncuffed Rusch endotracheal tube with a ... use saving you time and storage ... for easy identification and has a ...
... Clear Plus™ Cuffed Endotracheal Tube w. Flexi -Slip™ ... Single use. A quality Rusch endotracheal tube with ... saving you time and storage space. The stylet ... withdrawal. It is designed with a soft distal ...
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
Medicine Products: